Heartware, Inc. recalls HeartWare Ventricular Assist System Controller Product Usage: For use as a bridge-to-cardiac transplantation in patient…
- Recall date
- June 8, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0005-2017
- FDA classification
- Class I
- Brand / firm
- Heartware, Inc.
- Sold / distributed
- Worldwide Distribution - US Nationwide in the states of AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, IA, IL, IN, KY, LA, MA, MD, MI, MN, MO, MS, NC, NE, NJ, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, and WI and countries of Australia, Austria, Belgium, Canada, France, Germany, Lebanon, Malaysia, Sweden…
Why it was recalled
Loose connector ports in controller body.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
HeartWare Ventricular Assist System Controller Product Usage: For use as a bridge-to-cardiac transplantation in patients who are at risk of death from refractory end-stage left ventricular heart failure. The HVAD is designed for in-hospital and out-of-hospital settings, including transportation via fix-wing aircraft or helicopter
Get recall alerts
Free email alert whenever Heartware, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Heartware, Inc.